Oncological Desensitization in Hemato-Oncology and the role of the Nurse: a case study
Keywords:
Hypersensitivity reaction, Oncological desensitization, Nursing careAbstract
Associated with the emergence of new therapeutic weapons and the increased survival of cancer patients, there is an increased incidence of adverse reactions to chemotherapy.
Hypersensitivity Reaction (HR) is described as an unpredictable and dose-independent adverse drug reaction, and may be classified as mild, moderate, severe, or fatal, according to the patient’s symptomatology.
Before HR to antineoplastic drugs, haemato-oncological patients were deprived of the treatment of choice. Currently, Oncological Desensitization (OD) emerges as the therapeutic strategy that allows the re-introduction of the first line of treatment, safely and effectively, which translates into a new hope for these patients. In order to demonstrate the importance of the role of the Nurse in the patient to perform the DO, we present the case of a 22-year-old girl with diagnosis of Hodgkin’s lymphoma, hypersensitive to an antineoplastic drug and who complied with DO protocol, successfully.
Downloads
References
Caiado, J. (2016). Hipersensibilidade a fármacos - tratar, documentar e dessensibilizar. Revista Portuguesa de Imunoalergologia, 24(2), pp. 111-114.
Caiado, J., Rodrigues, T., Pedro, E., Costa, L., & Barbosa, M. P. (2009). Dessensibilização a fármacos em oncologia: Experiência de um serviço de Imunoalergologia. Revista Portuguesa de Imunoalergologia, 17(1), pp. 57-74.
Castells, M. (2006). Rapid desensitization for hypersensitivity reactions to chemotherapy agents. Current
Opinion in Allergy and Clinical Immunology, 6, pp. 271-277.
Jakel, P., Carsten, C., Carino, A., & Melinda, B. (April de 2016). Nursing Care of Patients undergoing Chemotherapy Desensitization: Part II. Clinical Jounal of oncology Nursing, 20(2), 137-139.
Jakel, P., Cynthia, C., Braskett, M., & Carino, A. (Abril de 2016). Nursing Care of patients undergoing Chemotherapy: Part I. Clinical Journal of Oncology Nursing, 20(1), 29-32.
Johansson, S., Bieber, T., Dahl, R., Friedmann, P., Lanier, B., & Lockey, R. (2004). Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of World Allergy Oragnization, Outuber 2003. Journal Allergy Clin Immunology, 113, pp. 832-836.
Lenz, H. (2007). Management and preparedness for infusion and hypersensitivity recations. Oncologist, 12(5), pp. 601-609.
Lenz, H. J. (s.d.). Management and preparedness for infusion and hypersensitivity reactions. Oncologist, 12, pp.601-609.
Raposo, J., Esteves, G., Lacerda, J., Martins, C., Lopes, C., Valle, S., . . . Alves, D. (2014). Serviço de Hematologia Transplantação de Medula - Protocolos de Abordagem terapêutica. Lisboa: Centro Hospitalar Lisboa Norte, E.P.E - Hospital de Santa Maria.
Regateiro, F., & Faria, E. (2016). Mecanismo Imunopatológicos das reações de hipersensibilidade a
fármacos. Revista Portuguesa de Imunoalergologia, 24(2), pp. 63-78.
Vogel, W. H. (April de 2010). Infusion Reactions: diagnosis, assessment, and management. Clinical Jounal of Oncology Nursing, 14(2), 10-21.
Winkeljohn, D., & Polovich, M. (2006). Carboplatin Hypersensitivity Reactions. Clinical Journal of Oncology Nursing, 10(5), pp. 595-598.
Zanotti, K., & Markman, M. (2001). Prevention and management of antineoplastic-induced hipersensitivity reactions. Drug Safety, 10, pp. 767-779.
Zetka, E. S. (Outubro de 2012). The essencial og Chemotherapy-Induced infusion reactions. Clinical Journal of Oncology Nursing, 10(5), 527-529.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Cláudia Gaspar, Ortélia Dias, Sónia Frias
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
